Use of Placebo in Supplementation Studies—Vitamin D Research Illustrates an Ethical Quandary

History has shown that without explicit and enforced guidelines, even well-intentioned researchers can fail to adequately examine the ethical pros and cons of study design choices. One area in which consensus does not yet exist is the use of placebo groups in vitamin supplementation studies. As a pr...

Full description

Bibliographic Details
Main Authors: Leigh A. Frame, Jonathan P. Fischer, Gail Geller, Lawrence J. Cheskin
Format: Article
Language:English
Published: MDPI AG 2018-03-01
Series:Nutrients
Subjects:
Online Access:http://www.mdpi.com/2072-6643/10/3/347
_version_ 1811229528243044352
author Leigh A. Frame
Jonathan P. Fischer
Gail Geller
Lawrence J. Cheskin
author_facet Leigh A. Frame
Jonathan P. Fischer
Gail Geller
Lawrence J. Cheskin
author_sort Leigh A. Frame
collection DOAJ
description History has shown that without explicit and enforced guidelines, even well-intentioned researchers can fail to adequately examine the ethical pros and cons of study design choices. One area in which consensus does not yet exist is the use of placebo groups in vitamin supplementation studies. As a prime example, we focus on vitamin D research. We aim to provide an overview of the ethical issues in placebo-controlled studies and guide future discussion about the ethical use of placebo groups. Research in the field of vitamin D shows variation in how placebo groups are used. We outline four types of control groups in use: active-control, placebo-control with restrictions on supplementation, placebo-control without supplementation restrictions, and placebo-control with rescue repletion therapy. The first two types highlight discrete ethical issues: active-control trials limit the ability to detect a difference; placebo-control trials that restrict supplementation potentially place subjects at risk of undue harm. The final two, placebo-control without supplementation restrictions or with rescue repletion therapy, offer potential solutions to these ethical challenges. Building on this, guidelines should be established and enforced on the use of placebo in supplementation studies. Furthermore, the field of vitamin D research has the potential to set an example worthy of emulation.
first_indexed 2024-04-12T10:16:01Z
format Article
id doaj.art-6a31efb58764439591236873255eebaa
institution Directory Open Access Journal
issn 2072-6643
language English
last_indexed 2024-04-12T10:16:01Z
publishDate 2018-03-01
publisher MDPI AG
record_format Article
series Nutrients
spelling doaj.art-6a31efb58764439591236873255eebaa2022-12-22T03:37:12ZengMDPI AGNutrients2072-66432018-03-0110334710.3390/nu10030347nu10030347Use of Placebo in Supplementation Studies—Vitamin D Research Illustrates an Ethical QuandaryLeigh A. Frame0Jonathan P. Fischer1Gail Geller2Lawrence J. Cheskin3The George Washington School of Medicine and Health Sciences, Washington, DC 20052, USAThe University of Chicago Pritzker School of Medicine, Chicago, IL 60637, USAThe Johns Hopkins School of Medicine, Baltimore, MD 21205, USAThe Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USAHistory has shown that without explicit and enforced guidelines, even well-intentioned researchers can fail to adequately examine the ethical pros and cons of study design choices. One area in which consensus does not yet exist is the use of placebo groups in vitamin supplementation studies. As a prime example, we focus on vitamin D research. We aim to provide an overview of the ethical issues in placebo-controlled studies and guide future discussion about the ethical use of placebo groups. Research in the field of vitamin D shows variation in how placebo groups are used. We outline four types of control groups in use: active-control, placebo-control with restrictions on supplementation, placebo-control without supplementation restrictions, and placebo-control with rescue repletion therapy. The first two types highlight discrete ethical issues: active-control trials limit the ability to detect a difference; placebo-control trials that restrict supplementation potentially place subjects at risk of undue harm. The final two, placebo-control without supplementation restrictions or with rescue repletion therapy, offer potential solutions to these ethical challenges. Building on this, guidelines should be established and enforced on the use of placebo in supplementation studies. Furthermore, the field of vitamin D research has the potential to set an example worthy of emulation.http://www.mdpi.com/2072-6643/10/3/347nutrition therapydietary supplementsresearch ethicsresearch designvitamin D
spellingShingle Leigh A. Frame
Jonathan P. Fischer
Gail Geller
Lawrence J. Cheskin
Use of Placebo in Supplementation Studies—Vitamin D Research Illustrates an Ethical Quandary
Nutrients
nutrition therapy
dietary supplements
research ethics
research design
vitamin D
title Use of Placebo in Supplementation Studies—Vitamin D Research Illustrates an Ethical Quandary
title_full Use of Placebo in Supplementation Studies—Vitamin D Research Illustrates an Ethical Quandary
title_fullStr Use of Placebo in Supplementation Studies—Vitamin D Research Illustrates an Ethical Quandary
title_full_unstemmed Use of Placebo in Supplementation Studies—Vitamin D Research Illustrates an Ethical Quandary
title_short Use of Placebo in Supplementation Studies—Vitamin D Research Illustrates an Ethical Quandary
title_sort use of placebo in supplementation studies vitamin d research illustrates an ethical quandary
topic nutrition therapy
dietary supplements
research ethics
research design
vitamin D
url http://www.mdpi.com/2072-6643/10/3/347
work_keys_str_mv AT leighaframe useofplaceboinsupplementationstudiesvitamindresearchillustratesanethicalquandary
AT jonathanpfischer useofplaceboinsupplementationstudiesvitamindresearchillustratesanethicalquandary
AT gailgeller useofplaceboinsupplementationstudiesvitamindresearchillustratesanethicalquandary
AT lawrencejcheskin useofplaceboinsupplementationstudiesvitamindresearchillustratesanethicalquandary